Physicians' Academy for Cardiovascular Education

Early intervention for lifetime CV risk reduction

Clinical updates in management of cardiovascular risk (1/4)

10' education - May 30, 2018 - Prof. John Deanfield, MD - University College London, London, UK - Online CME

CV risk factors that drive arterial disease in early life have a major impact on future CV risk. Communication about early lifestyle intervention to the public should be a major focus to reduce CV risk in later years.

Video navigation menu

  • Accumulation of atherosclerosis during pre-clinical phase has a major impact future CV risk 1:00
  • Exposure to risk factors over life drives future CV outcomes 4:55
  • Communicate the idea of intervention during early life to patients and public 6:48
  • CV factors in early life drive cognitive decline in later years 11:02
  • How early should prevention start? 12:24

Educational information

This educational video is part of a series of 4 videos with the theme: Clinical Updates in Management of Cardiovascular Risk.

Educational objectives are:


Prof. John E Deanfield, MD is Professor of Cardiology, Director, National Centre for Cardiovascular Prevention and Outcomes, University College London, United Kingdom


This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.


Funding for this educational program was provided by an unrestricted educational grant from Pfizer


This is available as accredited online CME for members. Click the button below to enroll:

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: